Comparison of the pharmacokinetics and pharmacodynamics of YH4808 in healthy subjects for defining an appropriate dosing regimen

YH4808 is a novel potassium-competitive acid blocker developed for gastric acid-related disorders. Previous studies indicate its potential to improve symptoms of gastric acid-related disorders. The current study was aimed to find the optimal regimen of YH4808 for night time pH control. This study wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoon, Sukyong, Oh, EunSil, Park, Min Soo, Jang, Seong Bok, Byun, Hae Mi, Park, Hyeonsoo, Kim, Heeyoung, Kim, Choon Ok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Clinical Pharmacology and Therapeutics 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492394/
https://www.ncbi.nlm.nih.gov/pubmed/34621707
http://dx.doi.org/10.12793/tcp.2021.29.e15

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492394/
https://www.ncbi.nlm.nih.gov/pubmed/34621707
http://dx.doi.org/10.12793/tcp.2021.29.e15

Ejemplares similares